Skip to main content
. 2023 Sep 29;63(20):6396–6411. doi: 10.1021/acs.jcim.3c00939

Figure 12.

Figure 12

(A–D) Alignment of the most active tubulin inhibitors with their respective pharmacophore models generated in LS and DS. (A) SC23 aligned to model SB2, (B) SC27 aligned to model LB8, (C) SC37 aligned to model LB6, and (D) SC24 aligned to model DS5.